human albumin 200 g/l baxalta
baxalta innovations gmbh, rakúsko - albumín - 75 - substitutio sanguinis (a krvnÉ derivÁty)
human albumin csl behring 200 g/l
csl behring gmbh, nemecko - albumín - 75 - substitutio sanguinis (a krvnÉ derivÁty)
albutein 200 g/l infúzny roztok
instituto grifols, s.a., Španielsko - albumín - 75 - substitutio sanguinis (a krvnÉ derivÁty)
albutein 50 g/l infúzny roztok
instituto grifols, s.a., Španielsko - albumín - 75 - substitutio sanguinis (a krvnÉ derivÁty)
colchicum-dispert
pharmaselect international beteiligungs gmbh, rakúsko - kolchicín - 29 - antirheumatica, antiphlogistica, antiuratica
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastické činidlá - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
rybrevant
janssen-cilag international n.v. - amivantamab - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
alburex 5
csl behring gmbh, nemecko - albumín - 75 - substitutio sanguinis (a krvnÉ derivÁty)
alburex 20
csl behring gmbh, nemecko - albumín - 75 - substitutio sanguinis (a krvnÉ derivÁty)
crealb 200 g/l infúzny roztok
sanquin plasma products b.v, holandsko - albumín - 75 - substitutio sanguinis (a krvnÉ derivÁty)